Liabilities / Assets
95th percentile
Higher debt load relative to assets than 95% of similar nonprofits.
990 • Fiscal year 2024 • EIN 82-3580514
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
95th percentile
Higher debt load relative to assets than 95% of similar nonprofits.
Liabilities / Revenue
90th percentile
Higher debt load relative to revenue than 90% of similar nonprofits.
Net Margin
81st percentile
Higher net margin than 81% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
84th percentile
Faster asset growth than 84% of similar nonprofits.
Revenue Growth
89th percentile
Faster revenue growth than 89% of similar nonprofits.
Assets
Up$312,901
Up $83,843 (+37%) from 2023
Net Assets
Up-$44,755
Up $126,508 (+74%) from 2023
Liabilities
Down$357,656
Down $42,665 (-11%) from 2023
Revenue
Up$516,500
Up $219,100 (+74%) from 2023
Expenses
Down$357,656
Down $42,665 (-11%) from 2023
Net Income
Up$158,844
Up $261,765 (+254%) from 2023
This 2024 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The mission of the NM Bioscience Authority is to increase awareness and support for New Mexico's bioscience sector by attracting capital investors, influencing policy and assisting in infrastructure and business development. The NM Bioscience Authority connects all necessary elements of Research & Development, Technology Transfer, Investment and Funding, and Workforce Development.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2024 • Form 990Summary only. Only limited summary data is available for this year.